Table 2 Types of evidence provided in the EEL-II
Authors study | Reference | Aim | Target of the study | Diagnostic sensitivity evidence provided |
|---|---|---|---|---|
R. Bhidayasiri. et al. | Treatment monitoring | To evaluate the efficacy of rotigotine transdermal patch in RCT, using a wearable sensor features as final endpoint | Significant differences, determined by statistical test p-values, in sensor-derived features before/after intervention | |
M. Iijima. et al. | Treatment monitoring | Objectively assessing gait disorder before/after medication change | Significant differences, determined by statistical test p-values, in sensor-derived features before/after the treatment change | |
H. Khodakarami et al. | Treatment monitoring | Predicting levodopa response using a machine learning algorithm trained on sensor data | AUC performance of machine learning algorithm when predicting 6 different classes of levodopa responses. | |
R. Bouça-Machado et al. | Treatment monitoring | To evaluate the efficacy of intervention using a wearable sensor features as final endpoint | Significant differences, determined by statistical test p-values, and effected size, determined as Cohen’s d, in sensor-derived features before/after intervention | |
N. Caballol et al. | Treatment monitoring | Analyzing the responsivity of sensor measure in detecting ON-OFF time, dyskinesia, Freezing | Significant differences, determined by statistical test p-values, in sensor-derived features between medication changed group and medication stable group. Kappa agreement analysis to evaluate the agreement between clinical interview and sensor results. | |
I. Thomas et al. | Intervention decision | Evaluating the accuracy of a sensor-based medication dosing schedules (SBDS) | Correlation and mean relative errors between sensor prediction and clinical experts’ evaluation | |
A. Silva de Lima et al. | Patient stratification | Evaluating Fall incidence rate in PD vs Controls using IMU wearable sensors | Significant differences, determined by statistical test p-values, in sensor-derived features across different patient populations | |
M. Mancini et al. | Patient stratification | Analyzing difference in turning between Freezers and not Freezer using IMU wearable sensors | Significant differences, determined by statistical test p-values, in sensor-derived features across different patient populations | |
L. Haertner et al. | Patient stratification | Evaluate difference in gait parameters in PD with and without Fear of Falling using IMUs sensors | Significant differences, determined by statistical test p-values, in sensor-derived features across different patient populations | |
K. Srulijes et al. | Patient stratification | Evaluating fall incidence rate in different disease population using IMU wearable sensors | Significant differences and correlations of sensor-derived features with patient diagnosis and clinical scores | |
M. Marano et al. | Patient stratification | Evaluating fall incidence rate in different patient population using IMU wearable sensors | Significant differences, determined by statistical test p-values, in sensor-derived features across different patient populations | |
M. Mancini et al. | Patient stratification | Automated detection of Freezing of Gait using IMU sensors data and detection of freezers vs non-freezers | Significant differences, determined by statistical test p-values, in sensor-derived features across different patient populations. Accuracy of FOG events detected compared with clinical rating | |
K. Kyritsis et al. | Patient stratification | Training a machine learning algorithm to distinguish PD vs Control from IMU sensor data during eating | AUC performance of machine learning algorithm in predicting patient diagnosis from sensor derived measures | |
A. Atrsaei et al. | Patient stratification | Evaluating the effect of fear of falling on sensor derived gait parameters | Significant differences, determined by statistical test p-values, in sensor-derived features across different patient populations | |
A. Mirelman et al. | Patient stratification, Disease prediction | To assess sleep disturbances in different PD vs Healthy Controls using objective sensor measures | Significant differences, determined by statistical test p-values, in sensor-derived features across different patient populations | |
V. Shah et al. | Disease prediction | To determine which sensor-derived mobility measures of discriminate PD from healthy control | AUC performance of machine learning algorithm | |
L. Adams et al. | Disease prediction | Evaluating difference in sensor-derived mobility parameters in PD vs Huntington patients | Significant differences, determined by statistical test p-values, in sensor-derived features across different disease populations | |
V. Shah Al. | Disease prediction | Evaluating difference in sensor-derived gait parameters in PD, Multiple Sclerosis and Healthy Controls. | Significant differences, determined by statistical test p-values, and AUC in sensor-derived features across different patient populations. | |
A. Nouriani. et al. | Disease prediction | Evaluate the predictive value of sensor-derived features for prospective fall frequency. | Linear regression analysis, between sensor-derived features and fall frequency prediction, rho, standard and mean squared error, t-stat and p-values are reported. | |
L. Evers et al. | Disease prediction, Symptom monitoring | To monitor motor fluctuations in PD using sensor derived measure during gait segment and to discriminate against healthy controls. | AUC performance of machine learning algorithm in predicting patient conditions and diagnosis from sensor derived measures. | |
H. Gaßner et al. | Symptom monitoring | To evaluate the reliability of supervised, standardized sensor-based gait outcomes at home compared to the hospital. | Significant differences, determined by statistical test p-values and intra class correlation coefficients, between sensor-derived features at home and in the lab. | |
L. Zhu et al. | Symptom monitoring | Correlating patient conditions with discrepancy between PROMs and Objective measures. | Correlation of sensor derived information with self-reported outcomes, rho and p-value. Statistical analysis with p-values and intra class correlation coefficients. | |
A. Rodríguez- Molinero et al. | Symptom monitoring | To investigate the link between gait sensor derived features and UPDRS III. | Correlation of sensor derived information with clinical scores, rho and p-value. | |
A. Rodríguez- Molinero et al. | Symptom monitoring | To investigate the link between sensor-derived gait measures ON-OFF state. | Accuracy and positive/negative predictive values of machine learning algorithm results based on sensor-derived features with patient-reported outcomes. | |
A. Lígia Silva de Lima et al. | Symptom monitoring | To investigate the link between motor fluctuations and sensor derived parameters. | Linear regression analysis, between sensor-derived features and clinical scores, rho and p-value, R2 before and after levodopa intake. | |
B. Boroojerdi et al. | Symptom monitoring | Evaluating correlation between total motor activity during sleep measured through sensors and patient reported sleep quality. | Descriptive statistic between sensor-derived features and patient reported outcomes. Difference between at home and at clinic behavior. | |
M. Knudson et al. | Symptom monitoring | Predicting from objective sensor measures activity of daily life impairment. | R2 performance of multiple regression algorithm, based on sensor-derived features, when predicting clinical scores. Significant differences in sensor values for patients with and without bradykinesia and dyskinesia, p-values reported. | |
A. Rodríguez-Molinero et al. | Symptom monitoring | Estimate dyskinesia severity from sensor-derived measurements. | Correlation of sensor derived information with Unified Dyskinesia Rating Scale, rho and p-value and confidence intervals. | |
Ravichandran. et al. | Symptom monitoring | Evaluate if sensor derived sensor derive features are sensitive to ON-OFF state. | Descriptive statistic of sensor derived value in different states. | |
A. Papadopoulos et al. | Symptom monitoring | Detecting tremor episode using smartphone IMU during phone calls. | Average and standard deviation of: Precision, Sensitivity, Specificity, F1-score performance of machine learning algorithm. | |
M. Heijmans et al. | Symptom monitoring | To evaluate symptom severity of people with PD through wearables and digital questionnaires. | AUC performance of logistic regression algorithm on a patient used as case study. | |
D. Gatsios et al. | Symptom monitoring | Feasibility study aiming to collect relevant clinical data in the wild. | Significant differences and correlations between sensor use and clinical scores, rho and p-value. | |
R. San-Segundo et al. | Symptom monitoring | Detecting tremor episode from sensor-derived data using deep learning algorithms. | AUC performance and False Positive Rate at 0.90 True Positive Rate of machine learning algorithm in predicting patient symptom severity | |
A. Abrami et al. | Symptom monitoring | To evaluate correlation between movement symbolic representation and clinical scores. | Significant differences and correlations between of sensor derived information with clinical scores, rho and R2. | |
R. Bouça-Machado et al. | Symptom monitoring | Feasibility study aiming to collect relevant clinical data in the wild via wearables. | Correlation of sensor derived information with clinical scores, rho and p-value. | |
M. Corrá et al. | Symptom monitoring | Evaluate if unsupervised sensor derived gait speed and walking bout duration detect ON-OFF state. | Significant differences and correlations between of sensor derived information with clinical scores, rho, p-value and R2. | |
Y. Raykov et al. | Symptom monitoring | To predict from gait sensor data if segment recorded happened before-after medication intake. | Mean and standard error in predicting patient conditions from sensor derived measures. | |
J. Habets et al. | Symptom monitoring | To detect significant difference in wrist IMU data during bradykinesia fluctuations and predicting them with a machine learning algorithm. | Significant differences, determined by statistical test F, Wilk’s Lambda and p-values. AUC performance of machine learning algorithm in predicting patient conditions from sensor derived measures | |
G. Oyama. et al. | Symptoms monitoring | To evaluate the test-retest reliability in the home environment of a digital sensor-based assessment. Correlation with in lab clinical scores. | Evaluation test-retest reliability across different study periods, determined by Intra class correlation coefficients. Spearman correlation between sensor measure at home and clinical scores at lab. | |
M. Hssayeni et al. | Symptom monitoring | To continuously predict UPDRS III from sensors recordings. | Correlation, determined by rho and p-value, and mean absolute errors between sensor prediction and clinical scores. | |
F. Lipsmeier et al. | Symptoms monitoring | Monitoring patient condition at home using a combination of unsupervised tasks and passive monitoring using objective sensor measures. | Spearman correlation, determined by rho and p-value, between sensor derived feature and clinical scores. Intra class correlation coefficients, evaluating test-retest reliability across different study periods. Significant differences, determined by statistical test p-values. | |
M. Burq et al. | Symptoms monitoring | Monitoring patient condition at home using a combination of unsupervised tasks and passive monitoring using objective sensor measures. | Correlation, determined by rho and confidence intervals, between sensor prediction and clinical scores. Intra class correlation, evaluating test-retest reliability across different study periods. | |
D. Safarpour et al. | Symptoms monitoring | Evaluating rigidity, postural instability and gait difficulties from wearables measures. | Correlation, determined via multivariable linear regression by rho and p-value, between sensor prediction and clinical scores measured in the lab. | |
FS. Kanellos. et al. | Symptom monitoring | Investigate the correlation between at lab and at home clinical assessment. | Correlation, determined by rho and p-value, between sensor prediction and clinical scores. Bland-Altman test between sensor prediction and clinical score. | |
JL. Adams. et al. | Disease prediction, Symptoms monitoring, Progression monitoring | Evaluate differences in digital features between early PD and controls. Links of sensor features and patient symptom severity. | Significant differences, determined by statistical test p-values, in sensor-derived features across different disease populations and patient conditions. | |
R. Powers et al. | Symptom monitoring, Progression monitoring, Intervention decision | Monitoring motor symptom severity using objective sensor measures. | Correlation of sensor derived information with clinical scores, rho and p-value. Significant differences, determined by statistical test p-values, in sensor-derived features across different patient conditions and populations. Accuracy comparison between sensor prediction and clinician’s expectation. |